Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001140361-26-000378 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | RCKT | Bjork Elisabeth | Dir | P - Purchase | $3.44 | +10.0K | 50.0K | +25% | +$34.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | P | A | 10,000 | $3.44 | 50,000 | D | — | — | (F1) Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026. |